Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEDROXYPROGESTERONE vs MELOXICAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEDROXYPROGESTERONE vs MELOXICAM: Safety Overview

Metric MEDROXYPROGESTERONE MELOXICAM
Total FAERS Reports 8,405 8,661
Deaths Reported 135 1,042
Death Rate 1.6% 12.0%
Hospitalizations 831 2,502
Average Patient Age 35.9 yrs 57.6 yrs
% Female Patients 98.1% 72.7%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 13, 2000
Manufacturer Pharmacia & Upjohn Company LLC Exelan Pharmaceuticals Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued